Drug Side Effects
Search
DISSEMINATED BLASTOMYCOSIS
DISSEMINATED BLASTOMYCOSIS
was reported 171 times
DISSEMINATED BLASTOMYCOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Selective T Cell Costimulation Blocker [EPC]
9
0.0019
1
Lipid-based Polyene Antifungal [EPC]
18
0.0014
2
CD52-directed Cytolytic Antibody [EPC]
10
0.0005
3
Polyene Antifungal [EPC]
18
0.0004
4
Carbonic Anhydrase Inhibitor [EPC]
7
0.0003
5
Echinocandin Antifungal [EPC]
2
0.0002
6
Interleukin-1 Receptor Antagonist [EPC]
3
0.0002
7
Calcineurin Inhibitor Immunosuppressant [EPC]
18
0.0001
8
Corticosteroid [EPC]
149
0.0001
9
Azole Antifungal [EPC]
17
0.0001
10
Lipopeptide Antibacterial [EPC]
1
0.0001
11
Antimetabolite Immunosuppressant [EPC]
2
0.0001
12
Sulfone [EPC]
1
0.0001
13
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0001
14
RNA Synthetase Inhibitor Antibacterial [EPC]
1
0.0001
15
CD20-directed Cytolytic Antibody [EPC]
21
0.0001
16
Rifamycin Antibacterial [EPC]
2
0.0001
17
Alkylating Drug [EPC]
13
0.0001
18
Alkaloid [EPC]
1
0.0000
19
Janus Kinase Inhibitor [EPC]
6
0.0000
20
Interleukin-6 Receptor Antagonist [EPC]
5
0.0000
21
Glycopeptide Antibacterial [EPC]
2
0.0000
22
Purine Antimetabolite [EPC]
2
0.0000
23
Kinase Inhibitor [EPC]
8
0.0000
24
Folate Analog Metabolic Inhibitor [EPC]
6
0.0000
25
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
1
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
9
0.0000
27
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
28
Nonsteroidal Anti-inflammatory Drug [EPC]
6
0.0000
29
Interleukin-4 Receptor alpha Antagonist [EPC]
1
0.0000